Results 11 to 20 of about 85,877 (261)

Extensive Lymphadenopathy in an HIV-Negative Patient With Multidrug-Resistant Tuberculosis. [PDF]

Respirol Case Rep
Extensive lymphadenopathy is uncommon in HIV‐negative patients with tuberculosis. This clinical image highlights the striking CT appearance of extensive extrapulmonary lymph node involvement in symptomatic multidrug‐resistant tuberculosis, even in the absence of HIV infection. ABSTRACT Tuberculous lymphadenitis is generally more severe in patients with
Araya T, Kita T, Iwasaki K, Higashi T, Hara R, Takato H.   +5 more
europepmc   +2 more sources

Multidrug-Resistant Tuberculosis

Chest, 2006
Multidrug-resistant tuberculosis (MDR-TB) caused by Mycobacterium tuberculosis resistant to both isoniazid and rifampicin with or without resistance to other drugs is among the most worrisome elements of the pandemic of antibiotic resistance. Globally, about three per cent of all newly diagnosed patients have MDR-TB.
S K, Sharma, A, Mohan
openaire   +3 more sources

Recurrent pneumothorax in a human immunodeficiency virus-positive patient with multidrug-resistant tuberculosis: a rare case of bronchopleural fistula: a case report

Journal of Medical Case Reports, 2022
Background Human immunodeficiency virus/tuberculosis coinfections have amplified the multidrug-resistant tuberculosis pandemic in many countries in Sub-Saharan Africa, and multidrug-resistant tuberculosis has become a major public health threat. There is
Lydia Nakiyingi, Joseph Baruch Baluku, Willy Ssengooba, Sharon Miriam Namiiro, Paul Buyego, Ivan Kimuli, Susan Adakun   +6 more
doaj   +1 more source

Survey data of multidrug-resistant tuberculosis, Tuberculosis patients characteristics and stress resilience during COVID-19 pandemic in West Sumatera Province, Indonesia

Data in Brief, 2020
This set of data presents a survey data describing multidrug-resistant tuberculosis, tuberculosis patients characteristics and stress resilience during COVID-19 pandemic in West Sumatera Province, Indonesia.
Ricvan Dana Nindrea, Nissa Prima Sari, Wirsma Arif Harahap, Samuel J. Haryono, Hari Kusnanto, Iwan Dwiprahasto, Lutfan Lazuardi, Teguh Aryandono   +7 more
doaj   +1 more source

Europe's contribution to the evaluation of the use of systemic antimicrobials in the treatment of periodontitis

Periodontology 2000, EarlyView., 2023
Abstract This narrative review celebrates Europe's contribution to the current knowledge on systemically administered antimicrobials in periodontal treatment. Periodontitis is the most frequent chronic noncommunicable human disease. It is caused by dysbiotic bacterial biofilms and is commonly treated with subgingival instrumentation.
David Herrera, Arie Jan van Winkelhoff, Paula Matesanz, Katalina Lauwens, Wim Teughels   +4 more
wiley   +1 more source

Microscopic-observation drug-susceptibility assay for the diagnosis of TB. [PDF]

, 2006
BACKGROUND: New diagnostic tools are urgently needed to interrupt the transmission of tuberculosis and multidrug-resistant tuberculosis. Rapid, sensitive detection of tuberculosis and multidrug-resistant tuberculosis in sputum has been demonstrated in ...
Caviedes, Luz, Coronel, Jorge, Escombe, A Roderick, Evans, Carlton AW, Friedland, Jon S, Gilman, Robert H, Hollm-Delgado, Maria-Graciela, LaChira, Doris, Moore, David AJ, Oberhelman, Richard, Piñedo, Yvette, Salazar, Cayo, Sanchez, Eduardo, Saravia, Juan Carlos, Vivar, Aldo   +14 more
core   +1 more source

Prevalence of multidrug-resistant tuberculosis in East Africa: A systematic review and meta-analysis.

PLoS ONE, 2022
BackgroundThe rate of multidrug-resistant tuberculosis is increasing at an alarming rate throughout the world. It is becoming an emerging public health problem in East Africa.
Kindu Alem Molla, Melese Abate Reta, Yonas Yimam Ayene   +2 more
doaj   +1 more source

Multidrug-resistant tuberculosis in middle ear: A case report

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2023
Background: Tuberculosis (TB) continues to be a common disease in developing countries, among which middle ear TB is rare. Furthermore, it is relatively difficult to make an early diagnosis and provide follow-up treatment for middle ear TB.
Tanze Cao, Xiuping Liu, Chengqing Yang, Chunlin Mei, Jiali Ou, Ronghui Du   +5 more
doaj   +1 more source

Drug-Resistant Tuberculosis--Current Dilemmas, Unanswered Questions, Challenges and Priority Needs [PDF]

, 2012
Tuberculosis was declared a global emergency by the World Health Organization (WHO) in 1993. Following the declaration and the promotion in 1995 of directly observed treatment short course (DOTS), a cost-effective strategy to contain the tuberculosis ...
Abubakar, Ibrahim, Atun, Rifat, Chakaya, Jeremiah, Cox, Helen, Ditiu, Lucica, Ford, Nathan, Grobusch, Martin, Hoelscher, Michael, Lawn, Stephen D., Maeurer, Markus, Marais, Ben, Mchugh, Timothy D., McNerney, Ruth, Memish, Ziad, Migliori, Giovanni-Battista, Mwaba, Peter, O'Grady, Justin, Pletschette, Michel, Ramsay, Andrew, Raviglione, Mario, Schito, Marco, Squire, S. Bertel, Swaminathan, Soumya, Zumla, Alimuddin   +23 more
core   +1 more source

Multidrug-resistant tuberculosis today [PDF]

Bulletin of the World Health Organization, 2012
The World Health Organization (WHO) and its partners have long conducted efforts to improve tuberculosis (TB) case surveillance and programme monitoring and evaluation. WHO’s 2011 report on global TB control1 provided the most reliable information ever generated on the burden of disease and death caused by TB and multidrug-resistant TB (i.e.
Matteelli, A., Centis, R., D'Ambrosio, L., Migliori, G. B.   +3 more
openaire   +4 more sources